Evolution of overall survival (OS) after curative-intent lung cancer surgery in a population-based Mississippi Delta cohort. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium.
The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
The March 20, 2024, article by Berman et al entitled “CML and the WHO: Why?” (J Clin Oncol 10.1200/JCO.23.01689) was published with an error. In the author list ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback